Donin Gleb, Erfányuková Anna, Ivlev Ilya
Department of Biomedical Technology, Czech Technical University in Prague, 272 01 Kladno, Czech Republic.
Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227, USA.
Vaccines (Basel). 2022 Feb 9;10(2):265. doi: 10.3390/vaccines10020265.
Young adults are a substantial driver of lagging vaccination against COVID-19 worldwide. We aimed to understand what vaccine or vaccination environment attributes may affect young adults' vaccine inclination. We contacted a convenience sample of 1415 students to recruit a minimum of 150 individuals for a web-based discrete choice experiment. The respondents were asked to choose one of two hypothetical vaccines, defined by six attributes-vaccine efficacy, risk of mild side effects, protection duration, administration route, recommender, and travel time to the vaccination site. Individual preferences were calculated with the Markov chain Monte Carlo hierarchical Bayes estimation. A total of 445 individuals (mean age 24.4 years, 272 (61.1%) women) completed the survey between 22 March and 3 May 2021. Vaccine protection duration (28.3 (95% CI, 27.0-29.6)) and vaccine efficacy in preventing COVID-19 (27.5 (95% CI, 26.3-28.8)) were the most important, followed by the risk of vaccine side effects (17.3 (95% CI, 16.2-18.4)). Individuals reluctant or unsure about vaccination (21.1%) prioritized the potential for mild side effects higher and vaccine efficacy lower than the vaccine-inclined individuals. New vaccination programs that target young adults should emphasize the protection duration, low risk of vaccine side effects, and high efficacy.
在全球范围内,年轻人是新冠疫苗接种滞后的一个重要推动因素。我们旨在了解哪些疫苗或接种环境属性可能会影响年轻人的疫苗接种意愿。我们联系了1415名学生的便利样本,招募至少150人参与一项基于网络的离散选择实验。受访者被要求从两种假设的疫苗中选择一种,这两种疫苗由六个属性定义——疫苗效力、轻度副作用风险、保护持续时间、接种途径、推荐者以及前往接种地点的行程时间。使用马尔可夫链蒙特卡罗分层贝叶斯估计来计算个人偏好。共有445人(平均年龄24.4岁,272人(61.1%)为女性)在2021年3月22日至5月3日期间完成了调查。疫苗保护持续时间(28.3(95%可信区间,27.0 - 29.6))和预防新冠的疫苗效力(27.5(95%可信区间,26.3 - 28.8))最为重要,其次是疫苗副作用风险(17.3(95%可信区间,16.2 - 18.4))。不愿接种或对接种不确定的个体(21.1%)比倾向接种疫苗的个体更看重轻度副作用的可能性,而对疫苗效力的看重程度较低。针对年轻人的新疫苗接种计划应强调保护持续时间、低疫苗副作用风险和高效力。